KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gilead Sciences (GILD) Cash from Financing Activities (2016 - 2025)

Gilead Sciences (GILD) has disclosed Cash from Financing Activities for 17 consecutive years, with -$1.3 billion as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Cash from Financing Activities fell 155.88% year-over-year to -$1.3 billion, compared with a TTM value of -$7.7 billion through Dec 2025, down 125.6%, and an annual FY2025 reading of -$7.7 billion, down 125.6% over the prior year.
  • Cash from Financing Activities was -$1.3 billion for Q4 2025 at Gilead Sciences, up from -$1.5 billion in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $2.3 billion in Q4 2024 and bottomed at -$3.5 billion in Q3 2021.
  • Average Cash from Financing Activities over 5 years is -$1.6 billion, with a median of -$1.5 billion recorded in 2023.
  • The sharpest move saw Cash from Financing Activities crashed 1582.44% in 2021, then skyrocketed 305.64% in 2024.
  • Year by year, Cash from Financing Activities stood at -$1.9 billion in 2021, then grew by 19.98% to -$1.6 billion in 2022, then rose by 29.28% to -$1.1 billion in 2023, then surged by 305.64% to $2.3 billion in 2024, then crashed by 155.88% to -$1.3 billion in 2025.
  • Business Quant data shows Cash from Financing Activities for GILD at -$1.3 billion in Q4 2025, -$1.5 billion in Q3 2025, and -$1.6 billion in Q2 2025.